Investigation of the Clinical Remission Course in Ulcerative Colitis from Tofacitinib Induction to Tapering or Withdrawal in Japanese Patients: A Single-Center Retrospective Study

Introduction: Tofacitinib (TOF), a Janus kinase inhibitor, has emerged as an innovative treatment option for patients with moderate-to-severe ulcerative colitis (UC). However, the clinical course of patients who achieve induction and maintain remission followed by TOF tapering or withdraw...

Full description

Saved in:
Bibliographic Details
Main Authors: Miki Koroku, Teppei Omori, Shun Murasugi, Ayumi Ito, Maria Yonezawa, Shinichi Nakamura, Katsutoshi Tokushige, Yousuke Nakai
Format: Article
Language:English
Published: Karger Publishers 2025-01-01
Series:Inflammatory Intestinal Diseases
Online Access:https://karger.com/article/doi/10.1159/000545704
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items